mRNA expression
Gene:
MAGEA12 (official gene symbol)Other symbol:
MAGEA12CT family:
CT1CT identifier:
CT1.12Aliases from NCBI:
MAGE12Gene expression pattern ? : Testis-selective
High-throughput data (expression in cancer samples)
SAGE(short, 10 nt tags) Show
SAGE(long, 17 nt tags) Show
MPSS (short, 13 nt tags) Show
EST Show
Validation by Ludwig Institute of Cancer Research of mRNA expression in normal tissues and cell lines (RT-PCR)
Show![]() | ||
![]() | ||
The figures shown in this section represent a standardized analysis of all reported CT-antigens in the same set of mRNA preparations from
normal human tissues and a selection of human cancer cell lines. The analysis was done by RT-PCR using the primer pairs indicated for each gene.
A total of 1.0 �g of RNA was reverse-transcribed into cDNA using the Omniscript RT kit (Qiagen, Valencia, CA) using oligo (dT)18 primers
(Invitrogen, Carlsbad, CA). JumpStart REDTaq� ReadyMix-(Sigma Aldrich, St. Louis,MO) was used for amplification according to the manufacturer's
instructions. Samples were amplified with a precycling hold at 95oC for 3 min, followed by 35 specific cycles of denaturation at 95oC
for 15 seconds,annealing for 30 seconds (10 cycles at 60oC, 10 cycles at 58oC and 15 cycles at 56oC) and extension at 72oC for 30 seconds followed by a final
extension step at 72oC for 7 minutes. The RT-PCR products were run on 1.5% agarose gels and stained by ethidium bromide. |
Published data of mRNA expression in normal tissues
ShowPublished data of mRNA expression in neoplasias
Hematologic malignacies Show
Tumor Subtype | Sample type | Frequency | Methodology | PMID |
---|---|---|---|---|
Monoclonal gammopathy of undetermined significance (MGUS) |
0/6 (0%) | RT-PCR | 10438702 | |
Myeloma |
0/2 (0%)(stage II) | RT-PCR | ||
Myeloma |
0/9 (0%)(stage I) | RT-PCR | ||
Myeloma |
4/26 (15%)(stage III) | RT-PCR |
Bladder cancer Show
Tumor Subtype | Sample type | Frequency | Methodology | PMID |
---|---|---|---|---|
Transitional cell carcinoma |
52/102 (51%) | RT-PCR | 21396841 |
Brain cancer Show
Tumor Subtype | Sample type | Frequency | Methodology | PMID |
---|---|---|---|---|
Medulloblastoma (Pediatric) |
5/11(45%) | qRT-PCR | 18398575 |
Hepatobiliary cancer Show
Tumor Subtype | Sample type | Frequency | Methodology | PMID |
---|---|---|---|---|
Hepatocellular carcinoma |
8/22 (38%) | RT-PCR | 10189127 |
Lung cancer Show
Tumor Subtype | Sample type | Frequency | Methodology | PMID |
---|---|---|---|---|
Non small cell lung carcinoma |
12/33 (36%) | qRT-PCR | 17066423 | |
Adenocarcinoma |
28/38 (74%) | Oligonucleotide microarray | 17208331 | |
Squamous cell carcinoma |
8/14 (57%) | Oligonucleotide microarray | ||
Adenocarcinoma |
4/29 (14%) | RT-PCR | 22138038 | |
Squamous cell carcinoma |
3/29 (10%) | RT-PCR |
Melanocytic lesion Show
Tumor Subtype | Sample type | Frequency | Methodology | PMID |
---|---|---|---|---|
Melanoma |
35/47 (74%) | RT-PCR | 10890380 | |
Melanoma |
5/6 (83%) | RT-PCR | 22707303 |
Sarcoma Show
Tumor Subtype | Sample type | Frequency | Methodology | PMID |
---|---|---|---|---|
Osteosarcoma |
13/28 (46%) | qRT-PCR | 22009167 |
Published data of mRNA expression in Cell Lines
ShowOrigin tissue | Cell Line ID | Frequency | Methodology | PMID |
---|---|---|---|---|
Colon carcinoma | IR806 SW403 |
2/3 (66%) | RT-PCR | 12100028 |
Colon carcinoma | MZ-CO-2 SK-CO-11 HSR 320 |
RT-PCR | 7927540 | |
Head and Neck carcinoma | BB49-HNC | 1/1 (100%) | Oligonucleotide microarray | 11751535 |
Leukemia | K562 | RT-PCR | 7927540 | |
Leukemia | K562 NB4 U937 |
3/7 (43%) | RT-PCR | 12399967 |
Lung carcinoma- SCLC | LBll LBI2 |
RT-PCR | 7927540 | |
Lung carcinoma- SCLC | OC1 | 1/1 (100%) | Oligonucleotide microarray | 11751535 |
Melanoma | MI10221 MZ2-MEL3.0 |
RT-PCR | 7927540 | |
Melanoma | NCC-KT G361 MMG-1 C32 RPMI7951 KU-MELTC-1 A375 TDMM1 SEK1 |
RT | 22707303 | |
Melanoma | LB1751-MEL LB373-MEL LB1448-MEL2 LB583-MEL6 LB1781-MEL AVL3-MEL |
6/9 (67%) | Oligonucleotide microarray | 11751535 |
Melanoma | Sk-Mel-37 Sk-Mel-29 Sk-Mel-28 Malme-3M |
4/5 (80%) | RT-PCR | 18395366 |
Thyroid carcinoma | TT | 1/1 (100%) | Oligonucleotide microarray | 11751535 |
2005-2009© CT Antigens Database